ArticlePharmaceutics2025

Development, Characterization, and Antimicrobial Evaluation of Hybrid Nanoparticles (HNPs) Based on Phospholipids, Cholesterol, Colistin, and Chitosan Against Multidrug-Resistant Gram-Negative Bacteria.

Isabella Perdomo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.